References
1. Tranquilli A.L., Dekker G., Magee L., et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014; 4: 97-104.
2. Magee L.A., Pels A., Helewa M., Rey E., et al.; Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens 2014; 4: 105-45.
3. Lowe S.A., Bowyer L., Lust K., et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol 2015; 55: e1-29.
4. Brown M.A., Magee L.A., Kenny L.C., et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice. Pregnancy Hypertens 2018; 13: 291-310.
5. Villar J., Say L., Gulmezoglu A.M., Meraldi M., et al. Eclampsia and pre-eclampsia: a health problem for 2000 years. In H. Critchly, A. MacLean, L. Post, J. Walk (eds). Pre-Eclampsia. London: RCOG Press, 2003: 189-207.
6. Ronsmans C., Graham W.J. Maternal mortality: who, when, where, and why. Lancet. 2006; 368: 1189-200.
7. Kuklina E.V., Ayala C., Callaghan W.M. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol.2009; 113: 1299-306.
8. Lisonkova S., Joseph K.S. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013; 209: 544.e1-12.
9. Lisonkova S., Sabr Y., Mayer C., Young C., et al. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol. 2014; 124: 771-81.
10. Redman C.W., Sargent I.L. Latest advances in understanding preeclampsia. Science. 2005; 308: 1592-4.
11. Jim B., Karumanchi S.A. Preeclampsia: pathogenesis, prevention, and long-term complications. Semin Nephrol. 2017; 37: 386-97.
12. Chaiworapongsa T., Chaemsaithong P., Yeo L., Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014; 10: 466-80.
13. Thilaganathan B. Pre-eclampsia and the cardiovascular-placental axis. Ultrasound Obstet Gynecol. 2018; 51: 714-7.
14. World Health Organization. WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. Geneva: WHO, 2011.
15. National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in Pregnancy: The management of Hypertensive Disorders during Pregnancy. London: RCOG Press, 2010.
16. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122: 1122-31.
17. Lowe S.A., Brown M.A., Dekker G.A., et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol. 2009; 49: 242-6.
18. Khalil A., Syngelaki A., Maiz N., Zinevich Y., et al. Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2013; 42: 634-43.
19. Lamminpaa R., Vehvilainen-Julkunen K., Gissler M., Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008. BMC Pregnancy Childb. 2012; 12: 47.
20. Yogev Y., Melamed N., Bardin R., Tenenbaum-Gavish K., et al. Pregnancy outcome at extremely advanced maternal age. Am J Obstet Gynecol. 2010; 203: 558.e1-7.
21. Balasch J., Gratacos E. Delayed childbearing: effects on fertility and the outcome of pregnancy. Curr Opin Obstet Gynecol. 2012; 24: 187-93.
22. Poon L.C.Y., Kametas N.A., Chelemen T., Leal A., et al. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010; 24: 104-10.
23. Duckitt K., Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330: 565.
24. Luo Z.-C., An N., Xu H.-R., Larante A., et al. The effects and mechanisms of primiparity on the risk of pre-eclampsia: a systematic review. Paediatr Perinat Epidemiol. 2007; 21 (suppl 1): 36-45.
25. Robillard P.Y., Hulsey T.C., Alexander G.R., Keenan A., et al. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J Reprod Immunol. 1993; 24: 1-12.
26. Hernandez-Diaz S., Toh S., Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009; 338: b2255.
27. Campbell D.M., MacGillivray I., Carr-Hill R. Pre-eclampsia in second pregnancy. Br J Obstet Gynaecol. 1985; 92: 131-40.
28. Sibai B.M., el-Nazer A., Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986; 155: 1011-6.
29. Lie R.T., Rasmussen S., Brunborg H., Gjessing H.K., et al. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ. 1998; 316: 1343-7.
30. Odegard R.A., Vatten L.J., Nilsen S.T., Salvesen K.A., et al. Risk factors and clinical manifestations of pre-eclampsia. BJOG. 2000; 107: 1410-6.
31. van Rijn B.B., Hoeks L.B., Bots M.L., Franx A., et al. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol. 2006; 195: 723-8.
32. Langenveld J., Jansen S., van der Post J., Wolf H., et al. Recurrence risk of a delivery before 34 weeks of pregnancy due to an early onset hypertensive disorder: a systematic review. Am J Perinatol. 2010; 27: 565-71.
33. Rousso D., Panidis D., Gkoutzioulis F., Kourtis A., et al. Effect of the interval between pregnancies on the health of mother and child. Eur J Obstet Gynecol Reprod Biol. 2002; 105: 4-6.
34. King J.C. The risk of maternal nutritional depletion and poor outcomes increases in early or closely spaced pregnancies. J Nutr.2003; 133: 1732S-6S.
35. Conde-Agudelo A., Rosas-Bermudez A., Kafury-Goeta A.C. Effects of birth spacing on maternal health: a systematic review. Am J Obstet Gynecol. 2007; 196: 297-308.
36. Mignini L.E., Carroli G., Betran A.P., et al. Interpregnancy interval and perinatal outcomes across Latin America from 1990 to 2009: a large multi-country study. BJOG. 2016; 123: 730-7.
37. Winikoff B. The effects of birth spacing on child and maternal health. Stud Fam Plann. 1983; 14: 231-45.
38. Klebanoff M.A. The interval between pregnancies and the outcome of subsequent births. N Engl J Med. 1999; 340: 643-4.
39. Jackson R.A., Gibson K.A., Wu Y.W., Croughan M.S. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol. 2004; 103: 551-63.
40. Trogstad L., Magnus P., Moffett A., Stoltenberg C. The effect of recurrent miscarriage and infertility on the risk of pre-eclampsia. BJOG. 2009; 116: 108-13.
41. Pandey S., Shetty A., Hamilton M., Bhattacharya S., et al. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum Reprod Update. 2012; 18: 485-503.
42. Thomopoulos C., Tsioufis C., Michalopoulou H., Makris T., et al. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review. J Hum Hypertens. 2013; 27: 148-57.
43. Martin A.S., Monsour M., Kawwass J.F., Boulet S.L., et al. Risk of preeclampsia in pregnancies after assisted reproductive technology and ovarian stimulation. Matern Child Health J. 2016; 20: 2050-6.
44. Albrecht E.D., Bonagura T.W., Burleigh D.W., Enders A.C., et al. Suppression of extravillous trophoblast invasion of uterine spiral arteries by estrogen during early baboon pregnancy. Placenta. 2006; 27: 483-90.
45. Imudia A.N., Awonuga A.O., Doyle J.O., et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012; 97: 1374-9.
46. Fisher S.J. Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol. 2015; 213: S115-22.
47. Smith G.N., Walker M., Tessier J.L., Millar K.G. Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. Am J Obstet Gynecol. 1997; 177: 455-8.
48. Hoy J., Venn A., Halliday J., Kovacs G., et al. Perinatal and obstetric outcomes of donor insemination using cryopreserved semen in Victoria, Australia. Hum Reprod. 1999; 14: 1760-4.
49. 49 Salha O., Sharma V., Dada T., et al. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod. 1999; 14: 2268-73.
50. Need J.A., Bell B., Meffin E., Jones W.R. Pre-eclampsia in pregnancies from donor inseminations. J Reprod Immunol. 1983; 5: 329-38.
51. Simeone S., Serena C., Rambaldi M.P., Marchi L., et al. Risk of preeclampsia and obstetric outcome in donor oocyte and autologous in vitro fertilization pregnancies. Minerva Ginecol. 2016; 68: 9-14.
52. Nakabayashi Y., Nakashima A., Yoshino O., et al. Impairment of the accumulation of decidual T cells, NK cells, and monocytes, and the poor vascular remodeling of spiral arteries, were observed in oocyte donation cases, regardless of the presence or absence of preeclampsia. J Reprod Immunol. 2016; 114: 65-74.
53. Arngrimsson R., Bjornsson S., Geirsson R.T., Bjornsson H., et al. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol. 1990; 97: 762-9.
54. Cincotta R.B., Brennecke S.P. Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynaecol Obstet. 1998; 60: 23-7.
55. Williams P.J., Broughton Pipkin F. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011; 25: 405-17.
56. Zintzaras E., Kitsios G., Harrison G.A., et al. Heterogeneity-based genome search meta-analysis for preeclampsia. Hum Genet.2006; 120: 360-70.
57. Cnattingius S., Bergstrom R., Lipworth L., Kramer M.S. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med. 1998; 338: 147-52.
58. Weiss J.L., Malone F.D., Emig D., et al. Obesity, obstetric complications and cesarean delivery rate - a population-based screening study. Am J Obstet Gynecol. 2004; 190: 1091-7.
59. Leung T.Y., Leung T.N., Sahota D.S., et al. Trends in maternal obesity and associated risks of adverse pregnancy outcomes in a population of Chinese women. BJOG. 2008; 115: 1529-37.
60. Syngelaki A., Bredaki F.E., Vaikousi E., Maiz N., et al. Body mass index at 11-13 weeks’ gestation and pregnancy complications. Fetal Diagn Ther. 2011; 30: 250-65.
61. Liu L., Hong Z., Zhang L. Associations of prepregnancy body mass index and gestational weight gain with pregnancy outcomes in nulliparous women delivering single live babies. Sci Rep. 2015; 5: 12863.
62. Rahman M.M., Abe S.K., Kanda M., et al. Maternal body mass index and risk of birth and maternal health outcomes in low- and middle-income countries: a systematic review and meta-analysis. Obes Rev. 2015; 16: 758-70.
63. Wei Y.-M., Yang H.-X., Zhu W.-W., et al. Risk of adverse pregnancy outcomes stratified for pre-pregnancy body mass index. J Matern Fetal Neonatal Med. 2016; 29: 2205-9.
64. Catalano P.M. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010; 140: 365-71.
65. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011; 29: 415-45.
66. Spradley F.T., Palei A.C., Granger J.P. Immune mechanisms linking obesity and preeclampsia. Biomolecules. 2015; 5: 3142-76.
67. Mittendorf R., Lain K.Y., Williams M.A., Walker C.K. Preeclampsia. A nested, case-control study of risk factors and their interactions. J Reprod Med. 1996; 41: 491-6.
68. Knuist M., Bonsel G.J., Zondervan H.A., Treffers P.E. Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study. Obstet Gynecol. 1998; 92: 174-8.
69. Mostello D., Catlin T.K., Roman L., Holcomb W.L.J., et al. Preeclampsia in the parous woman: who is at risk? Am J Obstet Gynecol.2002; 187: 425-9.
70. Caughey A.B., Stotland N.E., Washington A.E., Escobar G.J. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol. 2005; 106: 156-61.
71. Ghosh G., Grewal J., Mannisto T., et al. Racial/ethnic differences in pregnancy-related hypertensive disease in nulliparous women. Ethn Dis. 2014; 24: 283-9.
72. Russell R.B., Green N.S., Steiner C.A., et al. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics. 2007; 120: e1-9.
73. Burt V.L., Whelton P., Roccella E.J., et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995; 25: 305-13.
74. Kestenbaum B., Seliger S.L., Easterling T.R., et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis. 2003; 42: 982-9.
75. Bellamy L., Casas J.-P., Hingorani A.D., Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007; 335: 974.
76. Khalil A., Rezende J., Akolekar R., Syngelaki A., et al. Maternal racial origin and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2013; 41: 278-85.
77. Bartsch E., Medcalf K.E., Park A.L., Ray J.G. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016; 353: i1753.
78. Mudd L.M., Owe K.M., Mottola M.F., Pivarnik J.M. Health benefits of physical activity during pregnancy: an international perspective. Med Sci Sports Exerc. 2013; 45: 268-77.
79. Schneider S., Freerksen N., Rohrig S., Hoeft B., et al. Gestational diabetes and preeclampsia--similar risk factor profiles? Early Hum Dev. 2012; 88: 179-84.
80. Conti E., Zezza L., Ralli E., et al. Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards? Cytokine Growth Factor Rev. 2013; 24: 411-25.
81. de Resende Guimaraes M.F.B., Brandao AHF, de Lima Rezende C.A., et al. Assessment of endothelial function in pregnant women with preeclampsia and gestational diabetes mellitus by flow-mediated dilation of brachial artery. Arch Gynecol Obstet. 2014; 290: 441-7.
82. Kane S.C., da Silva Costa F., Brennecke S. First trimester biomarkers in the prediction of later pregnancy complications. Biomed Res Int. 2014; 2014: 807196.
83. Karacay O., Sepici-Dincel A., Karcaaltincaba D., et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diabetes Res Clin Pract. 2010; 89: 231-8.
84. Wiznitzer A., Mayer A., Novack V., et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol. 2009; 201: 482.e1-8.
85. Zhou J., Zhao X., Wang Z., Hu Y. Combination of lipids and uric acid in mid-second trimester can be used to predict adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 2012; 25: 2633-8.
86. Engeland A., Bjorge T., Daltveit A.K., et al. Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. Eur J Epidemiol. 2011; 26: 157-63.
87. Feig D.S., Shah B.R., Lipscombe L.L., et al. Preeclampsia as a risk factor for diabetes: a population-based cohort study. PLoS Med.2013; 10: e1001425.
88. Libby G., Murphy D.J., McEwan N.F., et al. Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia. 2007; 50: 523-30.
89. Mannisto T., Mendola P., Vaarasmaki M., et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013; 127: 681-90.
90. Parretti E., Lapolla A., Dalfra M., et al. Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension. 2006; 47: 449-53.
91. Sierra-Laguado J., Garcia R.G., Celedon J., et al. Determination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy-induced hypertension. Am J Hypertens. 2007; 20: 437-42.
92. Legro R.S. Insulin resistance in women’s health: why it matters and how to identify it. Curr Opin Obstet Gynecol. 2009; 21: 301-5.
93. Ryan E.A., Imes S., Liu D., et al. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes.1995; 44: 506-12.
94. D’Anna R., Baviera G., Corrado F., et al. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG. 2006; 113: 1264-9.
95. Soonthornpun K., Soonthornpun S., Wannaro P., Setasuban W., et al. Insulin resistance in women with a history of severe pre-eclampsia. J Obstet Gynaecol Res. 2009; 35: 55-9.
96. Fuh M.M.-T., Yin C.-S., Pei D., et al. Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy. Am J Hypertens. 1995; 8: 768-71.
97. Ray J.G. Dysmetabolic syndrome, placenta-mediated disease and future risk of cardiovascular disease. Fetal Matern Med Rev.2004; 15: 231-46.
98. Harborne L., Fleming R., Lyall H., Sattar N., et al. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88: 4116-23.
99. Girouard J., Giguere Y., Moutquin J.-M., Forest J.-C. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension. 2007; 49: 1056-62.
100.Beck D.W., Menezes A.H. Intracerebral hemorrhage in a patient with eclampsia. JAMA. 1981; 246: 1442-3.
101.Zhang J., Meikle S., Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003; 22: 203-12.
102.Chesley L.C., Annitto J.E., Cosgrove R.A. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol.1976; 124: 446-59.
103.Kaaja R. Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol 1998; 16: 41-6.
104.Garovic V.D., Hayman S.R. Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol.2007; 3: 613-22.
105.Craici I., Wagner S., Garovic V.D. Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis. 2008; 2: 249-59.
106.Brown M.C., Best K.E., Pearce M.S., Waugh J., et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013; 28: 1-19.
107.McDonald S.D., Malinowski A., Zhou Q., Yusuf S., et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008; 156: 918-30.
108.McDonald S.D., Han Z., Walsh M.W., Gerstein H.C., et al. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis. 2010; 55: 1026-39.
109.Fisher K.A., Luger A., Spargo B.H., Lindheimer M.D. Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine (Baltimore). 1981; 60: 267-76.
110.Vikse B.E., Irgens L.M., Leivestad T., Skjaerven R., et al. Preeclampsia and the risk of end-stage renal disease. N Engl J Med.2008; 359: 800-9.
111.Callaway L.K., Lawlor D.A., O’Callaghan M., Williams G.M., et al. Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study. Am J Obstet Gynecol. 2007; 197: 492.e1-7.
112.Carr D.B., Newton K.M., Utzschneider K.M., et al. Preeclampsia and risk of developing subsequent diabetes. Hypertens Pregnancy.2009; 28: 435-47.
113.Carty D.M., Delles C., Dominiczak A.F. Preeclampsia and future maternal health. J Hypertens. 2010; 28: 1349-55.